Φορτώνει......
Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction
Interleukin 6 receptor (IL6R) inhibitor, tocilizumab, has been effectively used in the treatment of cytokine release syndrome in patients receiving chimeric antigen receptor T-cell therapy. Here we present a patient with chronic myelomonocytic leukemia (CMML) who developed a steroid refractory, post...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Leuk Res Rep |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672312/ https://ncbi.nlm.nih.gov/pubmed/33240789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2020.100228 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|